SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-23
👔
ALTERITY THERAPEUTICS LTD
@ATHE_InsiderForm 4 Filing: Babarczy Julian Michael Acquires (Grant) shares of $ATHE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
ALTERITY THERAPEUTICS LTD
Ticker: $ATHE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-15
Shares: 2,000,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Babarczy Julian Michael, holds the title of Director at ALTERITY THERAPEUTICS LTD.
On 2026-06-15, the insider transacted 2,000,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Babarczy Julian Michael (Director) was granted $0 of $ATHE
Post-Transaction Position: 2,000,000 shares
SEC Accession No: 0002127744-26-000002 (CIK: 2127744)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.